Duloxetine Hydrochloride (LY248686) Protocol F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
Phase of Trial: Phase III
Latest Information Update: 15 May 2016
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder; Pain
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 18 Oct 2005 New trial record.
- 01 Jul 2005 Status changed from active, no longer recruiting to completed.